{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:46:13Z","timestamp":1762505173629},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.urology.2006.05.045","type":"journal-article","created":{"date-parts":[[2006,8,18]],"date-time":"2006-08-18T17:31:01Z","timestamp":1155922261000},"page":"3-8","source":"Crossref","is-referenced-by-count":80,"special_numbering":"S","title":["Patient-reported outcomes in overactive bladder: Importance for determining clinical effectiveness of treatment"],"prefix":"10.1016","volume":"68","author":[{"given":"Linda","family":"Brubaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin S.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2006.05.045_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1191\/0962280204sm357ra","article-title":"Patient reported outcomes as endpoints in medical research","volume":"13","author":"Fairclough","year":"2004","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.urology.2006.05.045_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/beog.1999.0079","article-title":"Quality of life and urinary incontinence","volume":"14","author":"Kelleher","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"issue":"suppl 2A","key":"10.1016\/j.urology.2006.05.045_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2006.05.044","article-title":"Assessment of treatment outcomes in patients with overactive bladder","volume":"68","author":"Abrams","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2006.05.045_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cct.2004.09.003","article-title":"Measuring treatment impact","volume":"25","author":"Willke","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.urology.2006.05.045_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta2140","article-title":"Evaluating patient-based outcome measures for use in clinical trials","volume":"2","author":"Fitzpatrick","year":"1998","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.urology.2006.05.045_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1016370925601","article-title":"Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire","volume":"11","author":"Coyne","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.urology.2006.05.045_bib7","first-page":"S580","article-title":"Overactive bladder significantly affects quality of life","volume":"6","author":"Abrams","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.urology.2006.05.045_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1464-410X.2005.05279.x","article-title":"The urgency of the problem and the problem of urgency in the overactive bladder","volume":"95","author":"Chapple","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2006.05.045_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2006.05.045_bib10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0149-2918(01)80104-1","article-title":"Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder","volume":"23","author":"Ricci","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.urology.2006.05.045_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1464-410X.2005.05889.x","article-title":"Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries","volume":"97","author":"Irwin","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2006.05.045_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1524-4733.2004.74008.x","article-title":"The impact of urinary urgency and frequency on health-related quality of life in overactive bladder","volume":"7","author":"Coyne","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.urology.2006.05.045_bib13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0090-4295(01)00986-4","article-title":"Health-related quality of life among adults with symptoms of overactive bladder","volume":"57","author":"Liberman","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2006.05.045_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1464-410X.2003.04463.x","article-title":"The impact on health-related quality of life of stress, urge and mixed urinary incontinence","volume":"92","author":"Coyne","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2006.05.045_bib15","first-page":"378","article-title":"Psychosocial impact of urinary incontinence in women","volume":"70","author":"Wyman","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.urology.2006.05.045_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/PL00004033","article-title":"The standardization of terminology for researchers in female pelvic floor disorders","volume":"12","author":"Weber","year":"2001","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.urology.2006.05.045_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00345-004-0455-3","article-title":"Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin","volume":"22","author":"Homma","year":"2004","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2006.05.045_bib18","first-page":"S616","article-title":"Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder","volume":"8","author":"Kelleher","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.urology.2006.05.045_bib19","first-page":"S608","article-title":"Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder","volume":"8","author":"Kelleher","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.urology.2006.05.045_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1464-410X.2004.05255.x","article-title":"Improved quality of life in patients with overactive bladder symptoms treated with solifenacin","volume":"95","author":"Kelleher","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2006.05.045_bib21","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","article-title":"A new questionnaire to assess the quality of life of urinary incontinent women","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.urology.2006.05.045_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.urology.2004.10.073","article-title":"Urgency","volume":"64","author":"Brubaker","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2006.05.045_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1464-410X.2005.05294.x","article-title":"The role of urinary urgency and its measurement in the overactive bladder symptom syndrome","volume":"95","author":"Chapple","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2006.05.045_bib24","first-page":"411","article-title":"The effect of anticholinergic therapy on urgency severity in patients with overactive bladder","volume":"22","author":"Dmochowski","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2006.05.045_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1464-410X.2005.05345.x","article-title":"Validation of the Urgency Perception Scale","volume":"95","author":"Cardozo","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2006.05.045_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00192-005-1300-y","article-title":"EGGS for patient-centered outcomes","volume":"16","author":"Brubaker","year":"2005","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.urology.2006.05.045_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1472-8206.2004.00234.x","article-title":"Assessment of patient-reported outcomes in clinical trials","volume":"18","author":"Wiklund","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"issue":"suppl 1","key":"10.1016\/j.urology.2006.05.045_bib28","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1524-4733.2005.00069.x","article-title":"The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue\u2014the BSW","volume":"8","author":"Pleil","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.urology.2006.05.045_bib29","doi-asserted-by":"crossref","unstructured":"Piault E, Evans C, Marcucci G, et al: Patient satisfaction: international development, translatability assessment and linguistic validation of the OAB-S, an overactive bladder treatment satisfaction questionnaire: ISPOR 8th Annual European Congress. Florence, Italy. Value in Health 8(6):A88(PUK36), 2005.","DOI":"10.1016\/S1098-3015(10)67412-8"},{"issue":"suppl 2","key":"10.1016\/j.urology.2006.05.045_bib30","first-page":"S103","article-title":"Linguistic validation of the overactive bladder questionnaire (OAB-q), OAB-q SF and the overactive bladder-validated 8 (OAB V8) screening questionnaire for this condition in Europe, Asia, North America, and South America","volume":"16","author":"Conway","year":"2005","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.urology.2006.05.045_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/02813439308994911","article-title":"Patient satisfaction and design of treatment","volume":"11","author":"Carlberg","year":"1993","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.urology.2006.05.045_bib32","first-page":"25","article-title":"Patient satisfaction as an indicator of quality care","volume":"25","author":"Cleary","year":"1988","journal-title":"Inquiry"},{"key":"10.1016\/j.urology.2006.05.045_bib33","first-page":"892","article-title":"How to survey patient satisfaction","volume":"15","author":"Ware","year":"1978","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.urology.2006.05.045_bib34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1524-4733.2003.65309.x","article-title":"Incorporating the patient\u2019s perspective into drug development and communication","volume":"6","author":"Acquadro","year":"2003","journal-title":"Value Health"},{"key":"10.1016\/j.urology.2006.05.045_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/009286150203600127","article-title":"Patient-reported outcomes","volume":"36","author":"Chassany","year":"2002","journal-title":"Drug Inf J"},{"key":"10.1016\/j.urology.2006.05.045_bib36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1008996223999","article-title":"Recommendations on health-related quality of life research to support labeling and promotional claims in the United States","volume":"9","author":"Revicki","year":"2000","journal-title":"Qual Life Res"},{"key":"10.1016\/j.urology.2006.05.045_bib37","year":"2002","journal-title":"European Agency for the Evaluation of Medicinal Products and Committee for Proprietary Medicinal Products"},{"key":"10.1016\/j.urology.2006.05.045_bib38","year":"2004","journal-title":"European Agency for the Evaluation of Medicinal Products and Committee for Proprietary Medicinal Products"},{"key":"10.1016\/j.urology.2006.05.045_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4065\/77.5.479","article-title":"Assessing the clinical significance of single items relative to summated scores","volume":"77","author":"Sloan","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urology.2006.05.045_bib40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00005650-199406000-00002","article-title":"Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview","volume":"32","author":"McHorney","year":"1994","journal-title":"Med Care"},{"key":"10.1016\/j.urology.2006.05.045_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0895-4356(95)00556-0","article-title":"Are health-related quality-of-life measures affected by the mode of administration?","volume":"49","author":"Weinberger","year":"1996","journal-title":"J Clin Epidemiol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429506007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429506007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T15:15:28Z","timestamp":1555773328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429506007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0090429506007734"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2006.05.045","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}